Skip to main content
This content is intended for customers outside the US. Click the link for specific information for the USA.
Go to the USA content
Home Novosanis
Menu
  • About us
  • Products
  • Home collection
  • Dataroom
    • White Papers
    • Posters
    • Publications
    • Brochures & Flyers
    • Instructions for use
    • Datasheets
  • News & Events
  • Contact
  • Careers
  • FAQs
  • International
  • USA

Posters

You are here

Home » Dataroom » Posters
Reset filters

Year

  • 2022 (1) Apply 2022 filter
  • 2021 (3) Apply 2021 filter
  • 2019 (3) Apply 2019 filter
  • 2017 (2) Apply 2017 filter
  • (-) Remove 2016 filter 2016

Event

  • (-) Remove ACTC filter ACTC
  • (-) Remove EUROGIN filter EUROGIN
  • (-) Remove KFG filter KFG

Application area

  • Device (3) Apply Device filter
    • Stabilization (2) Apply Stabilization filter
  • (-) Remove Infectious diseases filter Infectious diseases
    • (-) Remove HPV filter HPV

Author

  • Alex Vorsters (3) Apply Alex Vorsters filter
  • Severien Van Keer (1) Apply Severien Van Keer filter

Dataroom

Compatibility of Genefirst PapilloplexTM hrHPV genotyping assay for testing first- void urine specimens (EUROGIN 2016)

18/11/2016
Eurogin - Vorsters et al., 2016.

Pilot feasibility study on use of Cepheid Xpert HPV with Colli-Pee collected UCM preserved urine (EUROGIN 2016)

18/11/2016
Eurogin - Vorsters et al., 2016.

Evaluation of the Roche COBAS HPV assay with Colli-Pee collected, UCM preserved Urine (EUROGIN 2016)

18/11/2016
Eurogin - Vorsters et al., 2016.

Assessment of acceptability of first-void urine sampling for HPV DNA detection in young women (EUROGIN 2016)

26/10/2016
Eurogin - Van Keer et al., 2016.

Products

  • Colli-Pee
  • Home collection
  • Regulatory
  • Frequently Asked Questions

Communication

  • News
  • Infographics
  • Blogs
  • Press releases
  • Events
  • Podcasts & Webinars

Dataroom

  • White Papers
  • Posters
  • Publications
  • Brochures & Flyers
  • Instructions for use
  • Datasheets

Connect with us

Facebook
Instagram
Linkedin
Youtube
Twitter
Slideshare

Contact

Bijkhoevelaan 32c
2110 Wijnegem
Belgium
+32 3 485 50 16
welcome@novosanis.com

Disclaimer

Novosanis is a wholly owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology. The Colli-Pee® family, the heart of the company, allows volumetric and standardized collection of first-void urine. The platform consists of variants capturing a range of urine volumes for different application purposes. Urine collection through the Colli-Pee® device is easy, comfortable, and more accurate than a regular urine cup. First-void urine has shown to improve detection of infectious diseases, including sexually transmitted infections as well as for some cancers applications. The Colli-Pee® device enables immediate mixing of the first-void urine sample with a preservative, improving stability of the urine specimen. Novosanis markets its products worldwide and has a global customer base.

2022 © Novosanis, a subsidiary of OraSure Technologies, Inc., all rights reserved.

2022 © Novosanis

  • Cookie policy
  • Privacy Policy
  • Disclaimer
  • Terms & conditions
  • Quality policy

Drupal website by Dropsolid